These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 14872180

  • 21. Safety of the trivalent inactivated influenza vaccine among children: a population-based study.
    France EK, Glanz JM, Xu S, Davis RL, Black SB, Shinefield HR, Zangwill KM, Marcy SM, Mullooly JP, Jackson LA, Chen R.
    Arch Pediatr Adolesc Med; 2004 Nov; 158(11):1031-6. PubMed ID: 15520339
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.
    Avila Aguero ML, Soriano-Fallas A, Umaña-Sauma MA, Ulloa-Gutierrez R, Arnoux S.
    Medicina (B Aires); 2007 Nov; 67(4):351-9. PubMed ID: 17891930
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Current status of live attenuated influenza virus vaccine in the US.
    Belshe RB.
    Virus Res; 2004 Jul; 103(1-2):177-85. PubMed ID: 15163507
    [Abstract] [Full Text] [Related]

  • 29. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [Abstract] [Full Text] [Related]

  • 30. Live attenuated influenza virus vaccine trial in children.
    Hall CB, Douglas G, Fralonardo SA.
    Pediatrics; 1975 Dec; 56(6):991-8. PubMed ID: 1196767
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
    Belshe RB, Gruber WC, Mendelman PM, Mehta HB, Mahmood K, Reisinger K, Treanor J, Zangwill K, Hayden FG, Bernstein DI, Kotloff K, King J, Piedra PA, Block SL, Yan L, Wolff M.
    J Infect Dis; 2000 Mar; 181(3):1133-7. PubMed ID: 10720541
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Universal influenza vaccination and live attenuated influenza vaccination of children.
    Glezen WP.
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S104-9. PubMed ID: 18820568
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.
    Belshe RB, Ambrose CS, Yi T.
    Vaccine; 2008 Sep 12; 26 Suppl 4():D10-6. PubMed ID: 18611422
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.